Patents by Inventor Manish Raisinghani

Manish Raisinghani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
    Patent number: 9604945
    Abstract: Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: March 28, 2017
    Assignee: Caliper Life Sciences, Inc.
    Inventors: Hao Chen, Ming Liu, Qi Su, Manish Raisinghani
  • SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AND THEIR USE IN TREATING DOPAMINE RELATED DISORDERS
    Publication number: 20130281495
    Abstract: Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 24, 2013
    Inventors: Hao Chen, Ming Liu, Qi Su, Manish Raisinghani
  • Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
    Patent number: 8415385
    Abstract: Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
    Type: Grant
    Filed: July 12, 2011
    Date of Patent: April 9, 2013
    Inventors: Hao Chen, Ming Liu, Qi Su, Manish Raisinghani
  • SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AD THEIR USE IN TREATING DOPAMINE RELATED DISORDERS
    Publication number: 20110288137
    Abstract: Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
    Type: Application
    Filed: July 12, 2011
    Publication date: November 24, 2011
    Inventors: Hao Chen, Ming Liu, Qi Su, Manish Raisinghani
  • SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AND THEIR USE IN TREATING DOPAMINE RELATED DISORDERS
    Publication number: 20090215839
    Abstract: Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
    Type: Application
    Filed: April 24, 2009
    Publication date: August 27, 2009
    Inventors: Hao Chen, Ming Liu, Qi Su, Manish Raisinghani
  • SYDNONIMINES - SPECIFIC DOPAMINE REUPTAKE INHIBITORS AND THEIR USE IN TREATING DOPAMINE RELATED DISORDERS
    Publication number: 20080319030
    Abstract: Derivatives of Sydnonimine and its analogues, which bind selectively to dopamine transporter (DAT) proteins are useful for treating and delaying the progression of disorders and illnesses that are alleviated by inhibiting dopamine reuptake.
    Type: Application
    Filed: March 14, 2008
    Publication date: December 25, 2008
    Inventors: Hao Chen, Ming Liu, Qi Su, Manish Raisinghani